Lilly is a global healthcare leader that unites caring with discovery to create medicines for people around the world. To learn more about Lilly, please visit us at lilly.com and lilly.com/newsroom.
This content has been approved consistent with the US FDA. For additional questions or to report Lilly product related Adverse Event/Product Complaints, please contact The Lilly Answers Center at 1-800-LillyRx (1-800-545-5979).
Product Theater Presentation:
Date and Time:
Saturday, May 15, 2021
3:15pm - 4:15pm EST
Kristi Orbaugh, RN, MSN RNP, AOCN
Adult Nurse Practitioner
Community Hospital North
A CDK 4 & 6 Inhibitor With Overall Survival Data
This program is sponsored by and the speaker is presenting on behalf of Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.
PP-AL-US-2735 04/2021 © Lilly USA, LLC 2021. All rights reserved.
Verzenio® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.
|Verzenio Virtual Experience|
|Dosing and Administration Guide for Verzenio.pdf|
|MONARCH 2 Overall Summary of Results.pdf|
|Verzenio Continuous Care Program.pdf|
|Verzenio Prescribing Information|